GSK Salbutamol Programme
M2 Build is an Oral Solid Dose facility (OSD), producing tablets and capsules for the GSK brand.
The project was a blend of modular design (DFMA) and traditional ‘stick built’ construction.
Providing a GMP environment
DFMA Modular Design
Should you wish to know more about our role on Science, Research and Healthcare projects, please contact hello@iM2ltd.com
iM2 Role: Principal Designer
Simons Design Ltd
Sector: Science, Research & Healthcare
Start Date: July 2020
Completion: January 2023
Value: (£) Confidential